Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 4:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 29,042 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disease;Neurological Clear all

Conditions: Breast Cancer, Chronic Pain, Acute Pain, Depression, Anxiety
Interventions: Questionnaires, Mechanical Temporal Summation assessment, Pain threshold assessment; Other
Lead sponsor: KK Women's and Children's Hospital; Government
Eligibility: 21 Years to 80 Years · Female only
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Spinal Cord Injury
Interventions: Testosterone Gel applied by a pump, Stand Training, Electrical Stimulation; Drug · Other · Device
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 58 Years · Male only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Pain, Chronic, Opioid Use
Interventions: Interactive Music Therapy, Verbal-based support; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania

Conditions: Glioma of Brain, Craniopharyngioma, Ependymoma, Germ Cell Tumor
Interventions: Memantine, Placebo, Cognitive Assessment; Drug · Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 6 Years to 21 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Neurofibromatosis Type 1, Legius Syndrome
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 2 Years to 100 Years
Enrollment: 313 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Parkinson Disease
Interventions: Unilateral dual-target (STN/GPi) DBS; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obstructive Sleep Apnea, Maxillomandibular Advancement Surgery
Interventions: RCMP titration; Device
Lead sponsor: University of Michigan; Other
Eligibility: 30 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Pressure Ulcer, Spinal Cord Injuries
Interventions: Microcyn, Sterile saline; Drug · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Tardive Dyskinesia
Interventions: Valbenazine; Drug
Lead sponsor: Neurocrine Biosciences; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 27
States / cities: Anaheim, California • National City, California • Norwalk, California + 24 more

Conditions: Restless Leg Syndrome
Interventions: incobotulinumtoxinA, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Sleep Disturbance, Trauma
Interventions: Melatonin 5mg and Sleep Education, Placebo; Dietary Supplement · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Nose Deformity
Interventions: Mindfulness Pain Management Arm, Mindfulness Self Esteem Arm; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Baltimore, Maryland • Lutherville-Timonium, Maryland

Conditions: Myopathic Conditions
Interventions: cellulose placebo vs. atorvastatin; Drug
Lead sponsor: Scripps Health; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: San Diego, California

Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Kidney Cancer, Leukemia, Liver Cancer, Neuroblastoma, Ovarian Cancer, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: ixabepilone; Drug
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 2 Years to 21 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2010
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Chest Pain, Dyspnea, Syncope, Hypotension
Interventions: Point-of-care ultrasound, Usual care; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Exercise Training and Sarcopenia
Interventions: Exercise; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 60 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Lambert-Eaton Myasthenic Syndrome
Interventions: 3,4 DAP; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Amyloidosis, Hereditary, Amyloidosis Cardiac, Amyloidosis, Familial, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Transthyretin Gene Mutation
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 30 Years to 80 Years
Enrollment: 500 participants
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: New York, New York • Cleveland, Ohio • Dallas, Texas

Conditions: Memory Deficits, Electroconvulsive Therapy
Interventions: Cognitive Intervention: Memory Training, Comparable general mental stimulation; Behavioral
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Alzheimer Disease
Interventions: Gabapentin Enacarbil, Placebo Oral Tablet; Drug
Lead sponsor: University of Texas at Austin; Other
Eligibility: 55 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Intracranial Pressure, Intracranial Pressure Changes, Traumatic Brain Injury, Intracerebral Hemorrhage, Encephalitis, Encephalopathy, Hydrocephalus, Stroke, Autoregulation
Interventions: Not listed
Lead sponsor: CoMind Technologies Limited; Industry
Eligibility: 18 Years and older
Enrollment: 581 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 17
States / cities: Phoenix, Arizona • Sacramento, California • Wilmington, Delaware + 14 more

Conditions: Headache Disorders, Primary, Pain Management, Emergency Department
Interventions: Paracervical injection, prochlorperazine and diphenhydramine.(Standard Treatment); Drug
Lead sponsor: Christian Fromm, MD; Other
Eligibility: 18 Years to 64 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Migraine Disorders
Interventions: Occipital nerve stimulator; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 21 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 10
States / cities: Valencia, California • Chicago, Illinois • Shreveport, Louisiana + 5 more

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 45 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery

TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males

Pain Management Support Study for Cancer Survivors

Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors

Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD

Preliminary Evaluation of a RCMP to Predict Failure of Maxillomandibular Advancement Surgery for OSA

Pressure Ulcer Healing With Microcyn

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.

Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

Effects of Mindfulness Meditation on Rhinoplasty Outcomes

Is Myopathy Part of Statin Therapy (IMPOSTER-16)

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department

Time Efficient Exercise to Reverse Sarcopenia and Improve Cardio-metabolic Health

Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Cognitive Training for Memory Deficits Associated With Electroconvulsive Therapy

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

CoMind Early Feasibility Study

Paracervical Injection for Headache in the Emergency Department

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation